Patents by Inventor Florence Cabon

Florence Cabon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL DOUBLE-STRANDED OLIGONUCLEOTIDES FOR THE TREATMENT OF CANCER
    Publication number: 20210292755
    Abstract: Disclosed is a double-stranded oligonucleotide for the use thereof in the prevention and/or treatment of cancer, in association with a therapy that causes damage to DNA or prevents the repair thereof. Also disclosed is a double-stranded oligonucleotide for the use thereof in the prevention and/or treatment of cancer, with the exception of androgen-dependent prostate cancer.
    Type: Application
    Filed: October 27, 2017
    Publication date: September 23, 2021
    Inventors: Florence CABON, Hilary BROOKS, Stéphanie DELMAS, Maud CHUSSEAU
  • USE OF A SIRNA FOR TREATING CANCER
    Publication number: 20190336520
    Abstract: Disclosed is a composition including at least one siRNA, the siRNA hybridising with a coding or non-coding mNRA, in which it induces degradation or inhibits translation, the expression of the mRNA or of the protein for which it codes being implicated in a pathology, for the use of same in the prevention and/or the treatment of the pathology, the composition being formulated for a continuous systemic administration mode, and a device including such an administration mode.
    Type: Application
    Filed: August 8, 2017
    Publication date: November 7, 2019
    Inventors: Florence CABON, Hilary BROOKS, Maud CHUSSEAU, Stéphanie DELMAS
  • Oligonucleotides inhibiting cellular migration
    Patent number: 8765705
    Abstract: Oligonucleotides inhibiting cellular migration, and the use of at least one inhibitor of protein expression, which inhibits the expression of TSP1 protein, or a protein, which controls the expression of TSP1 or mediates the activity of TSP1, or one inhibitor of protein activity, this inhibitor inhibiting the activity of the TSP1 protein, in particular the activity responsible for the stimulation of cell migration, or one protein which controls the expression or mediates the activity of TSP1 for the manufacture of a drug for the prevention or the treatment of primary tumors or invasive or metastatic tumors.
    Type: Grant
    Filed: July 30, 2010
    Date of Patent: July 1, 2014
    Assignee: Centre National de la Recherche Scientifique
    Inventors: Florence Cabon, Virginie Firlej, Catherine Gallou-Kabani, Natalia Prevarskaya
  • OLIGONUCLEOTIDES INHIBITING CELLULAR MIGRATION
    Publication number: 20120195890
    Abstract: Oligonucleotides inhibiting cellular migration, and the use of at least one inhibitor of protein expression, which inhibits the expression of TSP1 protein, or a protein, which controls the expression of TSP1 or mediates the activity of TSP1, or one inhibitor of protein activity, this inhibitor inhibiting the activity of the TSP1 protein, in particular the activity responsible for the stimulation of cell migration, or one protein which controls the expression or mediates the activity of TSP1 for the manufacture of a drug for the prevention or the treatment of primary tumors or invasive or metastatic tumors.
    Type: Application
    Filed: July 30, 2010
    Publication date: August 2, 2012
    Applicant: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Florence Cabon, Virginie Firlej, Catherine Gallou-Kabani, Natalia Catherine Prevarskaya